Ovation Science Inc.
OVATF
$0.04
-$0.04-53.95%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -9.02% | 26.09% | -7.55% | -61.17% | -59.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.02% | 26.09% | -7.55% | -61.17% | -59.33% |
| Cost of Revenue | -- | 508.70% | 195.00% | -100.00% | -98.01% |
| Gross Profit | -6.72% | -94.57% | -54.65% | -60.13% | -20.13% |
| SG&A Expenses | -6.34% | 149.27% | 9.21% | -17.79% | -28.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.66% | 157.68% | 12.50% | -19.68% | -39.13% |
| Operating Income | 6.28% | -183.03% | -14.96% | 6.30% | 33.78% |
| Income Before Tax | 9.56% | -817.55% | 25.42% | -74.19% | 35.15% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.56% | -817.55% | 25.42% | -74.19% | 35.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.56% | -817.55% | 25.42% | -74.19% | 35.15% |
| EBIT | 6.28% | -183.03% | -14.96% | 6.30% | 33.78% |
| EBITDA | -- | -184.25% | -15.04% | 6.13% | 33.78% |
| EPS Basic | 16.67% | -840.00% | 24.32% | -47.37% | 36.84% |
| Normalized Basic EPS | 20.00% | -866.67% | 26.09% | -41.67% | 37.50% |
| EPS Diluted | 16.67% | -840.00% | 24.32% | -47.37% | 36.84% |
| Normalized Diluted EPS | 20.00% | -866.67% | 26.09% | -41.67% | 37.50% |
| Average Basic Shares Outstanding | 9.89% | 4.07% | 0.00% | 19.09% | 2.31% |
| Average Diluted Shares Outstanding | 9.89% | 4.07% | 0.00% | 19.09% | 2.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |